NinePoint Medical, Inc.: Chapter 11 case summary
ElevenFlo ·
NinePoint Medical’s Chapter 11 plan became effective on January 26, 2021, following confirmation and a sale transaction. The subsequent operating report Dkt. 159 was filed by the distribution trust’s liquidating trustee and reported a transfer to the trust, placing the case in the plan-implementation phase.
NinePoint Medical’s second amended Chapter 11 plan became effective on January 26, 2021, after the court confirmed it on January 7. The effective-date notice Dkt. 145 reported substantial consummation, and the subsequent operating report Dkt. 159 stated that the sale transaction closed on January 26. The report, filed by the NinePoint Medical Distribution Trust’s liquidating trustee, recorded a $16,697 transfer to the trust for the reporting period.
NinePoint, a medical-device manufacturer, filed for Chapter 11 on October 16, 2020, after cash shortages forced it to lay off its employees and cease operations in March. Its lender, Merit Medical Systems, declined to exercise an acquisition option and declared a loan default in June. The first-day declaration Dkt. 12 reported $10,500,000 of outstanding loan principal at filing and approximately $12,892,274 including interest.
After a marketing process, NinePoint reached a restructuring agreement with Merit and Tall Marmot, LLC, under which Tall Marmot would acquire the reorganized company’s equity. The final financing order Dkt. 101 authorized up to $1,550,000 in secured postpetition financing from Tall Marmot and use of Merit's cash collateral. The confirmation order Dkt. 136 confirmed the plan, and the transaction and plan effectiveness followed on January 26.
Sources
- Dkt. 12First Day DeclarationFiled Oct 28, 2020Oct 28, 2020
- Dkt. 101Order (Final) Pursuant to 11 U.S.C. §§ 105, 361, 362, 363(c), 364(c)(1), 364(c)(2), 364(d)(1), 364(e) and 507 (I) Authorizing Debtor to (A) Obtain Postpetition Secured Financing From Tall Marmot, LLC; (B) Utilize Cash Collateral; and (C) Pay Certain Related Fees and Charges; (II) Granting Adequate Protection to the Prepetition Lender; (III) Modifying the Automatic Stay; and (IV) Granting Certain Related Relief (Related Document(s)[16], [36], [98]) Order Signed on 11/20/2020. (Mml)Filed Nov 20, 2020Nov 20, 2020
- Dkt. 136Findings of Fact, Conclusions of Law, and Order Approving the Disclosure Statement for, and Confirming, the Second Amended Chapter 11 Plan of Reorganization of NinePoint Medical, Inc. (Related Document(s)[65], [66], [127], [129], [130], [131], [132], [133]) Signed on 1/7/2021. (Attachments: # (1) Exhibit A # (2) Exhibit B) (CB)Filed Jan 7, 2021Jan 7, 2021
- Dkt. 145Notice of Effective Date Notice of (A) Entry of Order Approving the Disclosure Statement for, and Confirming, the Second Amended Chapter 11 Plan of Reorganization of NinePoint Medical, Inc., (B) Effective Date of the Plan; (C) Substantial Consummation of the Plan; and (D) Bar Dates for Certain Administrative Professional, and Rejection Claims (Related Document(s)[136]) Filed by NinePoint Medical, Inc.. (Hurst, David)Filed Jan 26, 2021Jan 26, 2021
- Dkt. 159Monthly Operating Report (Jan 1–26, 2021)Filed Mar 5, 2021Mar 5, 2021